« Back
Home /
Paclitaxel-13C6

Paclitaxel-13C6

Manufacturer	Toronto Research Chemicals
Category	Oncology
Type	Biochemicals
Specific against	other
Amount	0,5mg
Item no.	TRC-P132504-0,5mg
eClass 6.1	32160405
eClass 9.0	32160490
Available
Mol. Formula	C4113C6H51NO14
Mol. Weight	859, 86
Subcategory	Aromatics, Chiral Reagents, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals,
Appearance	White to Off-White Solid
Application Notes	Paclitaxel-13C is the labeled analogue of Paclitaxel (P132500).Paclitaxel is an antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy.
Melting Pt.	No Data Available
Boiling Pt.	No Data Available
Solubility	Chloroform (Slightly), Methanol (Slightly)
Stability	No Data Available
Storage Condition	-20C Freezer

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0,5mg

available

Delivery expected until 6/6/2024